Oleic acid produced by a marine Vibrio spp. acts as an anti-Vibrio parahaemolyticus agent

Marine Drugs

Volumn 9, Issue 10, 2011, Pages 2155-2163

  Leyton, Yanett ^a   Borquez, Jorge ^a   Darias, José ^b   Cueto, Mercedes ^b   Díaz Marrero, Ana R ^b   Riquelme, Carlos ^a  

^a UNIVERSIDAD DE ANTOFAGASTA   (Chile)

^b INSTITUTO DE PRODUCTOS NATURALES Y AGROBIOLOGÍA   (Spain)

Author keywords

Bioactive marine products; Inhibition; Oleic acid; Vibrio parahaemolyticus

Indexed keywords

LINOLEIC ACID; LINOLENIC ACID; OLEIC ACID;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG ISOLATION; DRUG PURIFICATION; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSED PHASE LIQUID CHROMATOGRAPHY; SPECTROMETRY; VIBRIO PARAHAEMOLYTICUS;

BACTERIA (MICROORGANISMS); VIBRIO; VIBRIO PARAHAEMOLYTICUS;

EID: 80054929109     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md9102155     Document Type: Article

References (26)

1. Duque, B. Busqueda de compuestos bioactivos a partir de organismos marinos del caribe colombiano. Rev. Acad. Colomb. Cienc. 1998, 22, 527-537.
2. Newman, D.J.; Cragg, G.M. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 2004, 67, 1216-1238. (Pubitemid 39145623)
3. AL-Zereini, W. Natural Products from Marine Bacteria. Ph.D. Thesis, Technischen Universität Kaiserslautern, Kaiserslautern, Germany, September 2006.
4. Márquez, D.; Galeano, E.; Martínez, A. Productos naturales con actividad antimicrobiana. Parte II. Vitae Rev. Fac. Quím. Farm. 2004, 11, 35-41.
5. Blunt, J.W.; Copp, B.R.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2006, 23, 26-78.
6. Zapata, M.; Silva, S.; Luza, Y.; Wilkens, M.; Riquelme, C. The inhibitory effect of biofilms produced by wild bacterial isolates to the larval settlement of the fouling ascidia Ciona intestinalis and Pyura praeputialis. Electron. J. Biotechnol. 2007, 10, 149-159.
7. Zhang, Y.; Mu, J.; Gu, X.; Zhao, C.; Wang, X.; Xie, Z. A Marine sulfate-reducing bacterium producing multiple antibiotics: Biological and chemical investigation. Mar. Drugs 2009, 7, 341-354.
8. Parés, R.; Juárez, A. Bioquímica de los Microorganismos; Editorial Reverté: Barcelona, Spain, 1997; pp. 1-380.
9. Cai, J.; Li, J.; Thompson, K.D.; Li, C.; Han, H. Isolation and characterization of pathogenic Vibrio parahaemolyticus from diseased post-larvae of abalone Haliotis diversicolor supertexta. J. Basic Microbiol. 2007, 47, 84-86. (Pubitemid 46952908)
10. Balcazar, J.L.; Rojas-Luna, T.; Cunningham, D. Effect of the addition of four potential probiotic strains on the survival of pacific white shrimp (Litopenaeus vannamei) following immersion challenge with Vibrio parahaemolyticus. J. Invert. Pathol. 2007, 96, 147-150. (Pubitemid 47390706)
11. Isnansetyo, A.; Istiqomah, I.; Muhtadi; Sinansari, S.; Hernawan, R.K.; Triyanto; Widada, J. A potential bacterial biocontrol agent, strain S2V2 against pathogenic marine Vibrio in aquaculture. World J. Microbiol. Biotechnol. 2009, 25, 1103-1113.
12. Harth, E.; Matsuda, L.; Hernández, C.; Rioseco, M.L.; Romero, J.; González-Escalona, N.; Martínez-Urtaza, J.; Espejo, R. Epidemiology of Vibrio parahaemolyticus Outbreaks, Southern Chile. J. Infect. Dis. 2009, 15, 163-168.
13. Zheng, C.J.; Yoo, J.S.; Lee, T.G.; Cho, H.Y.; Kim, Y.H.; Kim, W.G. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett. 2005, 579, 5157-5162.
14. Lekogo, B.M.; Coroller, L.; Mathot, A.G.; Mafart, P.; Leguerinel, I. Modelling the influence of palmitic, palmitoleic, stearic and oleic acids on apparent heat resistance of spores of Bacillus cereus NTCC 11145 and Clostridium sporogenes Pasteur 79.3. Int. J. Food Microbiol. 2010, 141, 242-247.
15. Nieman, C. Influence of trace amounts of fatty acids on the growth of microorganisms. Bacteriol. Rev. 1954, 18, 147-163.
16. Singh, I.P.; Milligan, K.E.; Gerwick, W.H. Tanikolide, a toxic and antifungal lactone from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 1999, 62, 1333-1335. (Pubitemid 29463344)
17. Leyton, Y.; Riquelme, C. Marine Bacillus spp. Associated with the egg capsule of Concholepas concholepas (common name "loco") have an inhibitory activity toward the pathogen Vibrio parahaemolyticus. Microb. Ecol. 2010, 60, 599-605.
18. Jorquera, M.; Riquelme, C.; Loyola, L.; Muñoz, L. Production of bactericidal substance by a marine Vibrio isolated from cultures of the scallop Argopecten purpuratus. Aquac. Int. 1999, 7, 433-448. (Pubitemid 30221537)
19. Sun, C.Q.; O'Connor, C.J.; Roberton, A.M. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol. Med. Microbiol. 2003, 36, 9-17. (Pubitemid 36515078)
20. Fuenzalida, L.; Armijo, L.; Zabala, B.; Hernández, C.; Rioseco, M.L.; Riquelme, C.; Espejo, R. Vibrio parahaemolyticus strains isolated during investigation of the summer 2006 seafood related diarrhea outbreaks in two regions of Chile. Int. J. Food Microbiol. 2007, 117, 270-275. (Pubitemid 46992754)
21. Seidel, V.; Taylor, P.W. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria. Int. J. Antimicrob. Agents 2004, 23, 613-619. (Pubitemid 38759678)
22. Sun, C.Q.; O'Connor, C.J.; Roberton, A.M. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol. Med. Microbiol. 2003, 36, 9-17. (Pubitemid 36515078)
23. Farrington, M.; Brenwald, N.; Haines, D.; Walpole, E. Resistance to desiccation and skin fatty acids in outbreak Straits of methicillin-resistant Staphylococcus aureus. J. Med. Microbiol. 1992, 36, 56-60.
24. Nicolosi, R.J.; Woolfrey, B.; Wilson, T.A.; Scollin, P.; Handelman, G.; Fisher, R. Decreased aortic early atherosclerosis and associated risk factors in hypercholesterolemic hamsters fed a high or mid oleic acid oil compared to a high-linoleic acid oil. J. Nutr. Biochem. 2004, 15, 540-547. (Pubitemid 39209397)
25. Ziboh, V.A.; Miller, C.C.; Cho, Y. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: Generation of anti-inflammatory and antiproliferative metabolites. Am. J. Clin. Nutr. 2000, 71, 361S-366S.
26. Lunde, C.S.; Hartouni, S.R.; Janc, J.W.; Mammen, M.; Humphrey, P.P.; Benton, B.M. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob. Agents Chemother. 2009, 53, 3375-3383.